ASX/RAC (ASX/RAC)

Australian Securities Exchange: ASX/RAC · AUD

A$1.52

-0.02 (-1.3%)· Recorded snapshot

Market cap	297M
Revenue (ttm)	2.8M
Net income (ttm)	-11.1M
EPS (ttm)	-A$0.06
Shares out	196.1M
Volume	132,557
Beta	0.91

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.8M
Net income (ttm): -11.1M
EPS (ttm): -A$0.06
Market cap: 297M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-42.3

P25 n/aP50 n/aP75 n/a

ROIC-24.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/RAC indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

AUD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-27
Enterprise value	AUD 262.8M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2011
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000RAC3
Last earnings date	2026-02-25
Last refreshed	2026-10-28
Market cap	AUD 297M
Next earnings date	2026-11-27
Price	AUD 1.52
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	asx/RAC
Website	https://racuraoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.09%
EV/Sales	93.47x
FCF / EV yield	-3.14%
FCF yield	-2.78%
Industry forward P/E	28.55x
P/B ratio	8.15x
P/S ratio	105.67x
Price / tangible book value	8.69x
Sector forward P/E	34.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	61.22%
Operating margin	-370.08%
Pretax margin	-394.46%
ROA	-23.4%
ROA (5Y)	-25.55%
ROCE	-28.52%
ROE	-42.28%
ROE (5Y)	-42.09%
ROIC	-24.79%
SBC / revenue	41.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-62.74%
Gross profit growth 3Y	15.81%
Net income growth years	0
Revenue growth	-46.5%
Revenue growth 3Y	-3.56%
Revenue growth 5Y	48.64%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -3,674
Depreciation and amortization	AUD 281,313
EBIT	AUD -10.4M
EBITDA	AUD -10.1M
EPS	AUD -0.06
FCF per share	AUD -0.04
Financing cash flow	AUD 28.9M
Free cash flow	AUD -8.3M
Free cash flow minus SBC	AUD -9.4M
Gross profit	AUD 1.7M
Investing cash flow	AUD -3,142
Net cash flow	AUD 20.6M
Net income	AUD -11.1M
Operating cash flow minus SBC	AUD -9.4M
Operating income	AUD -10.4M
Revenue	AUD 2.8M
Stock-based compensation	AUD 1.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	160.63
Book value per share	AUD 0.19
Debt / equity	0
Long-term assets	AUD 3.5M
Long-term liabilities	AUD 28,344
Net cash (debt)	AUD 34.3M
Net cash / market cap	11.54%
Net cash growth	150.92%
Net debt / equity	-0.94
Piotroski F-Score	2
Property, plant and equipment	AUD 3,556
Shareholders' equity	AUD 36.4M
Tangible book value	AUD 34.2M
Tangible book value per share	AUD 0.17
Total assets	AUD 38.1M
Total cash	AUD 34.3M
Total debt	AUD 0
Total liabilities	AUD 1.6M
WACC	9.27%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.1
Current assets	AUD 34.6M
Current liabilities	AUD 1.6M
Current ratio	21.43
Net working capital	AUD -1.3M
Quick ratio	21.28
Working capital	AUD 33M
Working capital turnover	0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.9%
Shareholder yield	-3.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	471.7%
10Y return CAGR	19.05%
10Y total return	471.7%
150-day SMA	AUD 2.25
1D price change	-1.3%
1M price change	-26.1%
1M total return	-26.1%
1W price change	-2.88%
1W total return	-2.88%
1Y price change	-54.78%
1Y return CAGR	-54.8%
1Y total return	-54.78%
20-day SMA	AUD 1.68
200-day SMA	AUD 2.29
3M price change	-26.81%
3M total return	-26.81%
3Y price change	54.59%
3Y return CAGR	15.62%
3Y total return	54.59%
50-day SMA	AUD 1.92
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 3.79
52-week high date	2025-11-17
52-week low	AUD 1.52
52-week low date	2026-10-28
5Y price change	-52.95%
5Y return CAGR	-14%
5Y total return	-52.95%
6M price change	-44.3%
6M total return	-44.3%
All-time high	AUD 4.90
All-time high date	2025-10-13
All-time low	AUD 0.05
All-time low date	2019-07-24
Average true range (ATR)	AUD 0.09
Average volume	70.7K
Beta (1Y)	0.48
Beta (2Y)	0.05
Beta (5Y)	0.91
Change from 52-week high	-60.03%
Change from 52-week low	0%
Change from all-time high	-69.08%
Change from all-time low	3,266.67%
Change from open	-5.31%
Day's gap	4.23%
Dollar volume	AUD 200,824
High price	AUD 1.61
Low price	AUD 1.52
Monthly RSI	43.14
Open price	AUD 1.60
Position in 52-week range	0%
Previous close	AUD 1.54
Price vs 150-day SMA	-32.73%
Price vs 20-day SMA	-9.77%
Price vs 200-day SMA	-33.96%
Price vs 50-day SMA	-21.01%
Relative volume	1.88
RSI	30.79
Sharpe ratio	-1.09
Sharpe ratio (3Y)	0.52
Sharpe ratio (5Y)	0.06
Sortino ratio	-1.47
Sortino ratio (3Y)	1
Sortino ratio (5Y)	0.19
Volume	132.6K
Weekly RSI	31.11
YTD price change	-44.51%
YTD total return	-44.51%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	136.3M
Shares change (QoQ)	3.67%
Shares change (YoY)	3.9%
Shares held by insiders	28.24%
Shares held by institutions	2.43%
Shares outstanding	196.1M

Deeper analysis on ASX/RAC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/RAC report

Is a complete ASX/RAC research report available?

No complete published report is available for asx/RAC (ASX/RAC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/RAC (ASX/RAC)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/RAC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/RAC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/RAC

Frequently asked questions